Skip to content
easybpt
Browse topics

Pharmacology

Calcium channel blockers

How dihydropyridine and non-dihydropyridine calcium channel blockers act on L-type channels in vascular smooth muscle, myocardium and nodal tissue, and how that tissue selectivity explains their uses, oedema, interactions and overdose.

Tier 2Medical sciences concept

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions8 flashcards

At a glance

  • Calcium channel blockers (CCBs) block the L-type (Cav1.2) channel, which carries calcium into vascular smooth muscle, cardiac myocytes and SA and AV nodal cells.
  • Dihydropyridines (amlodipine, felodipine, lercanidipine, nifedipine, nimodipine) are vascular-selective: vasodilation with little direct cardiac effect.
  • Verapamil (phenylalkylamine) is cardiac-selective, and diltiazem (benzothiazepine) is in between. Both slow the SA and AV nodes and depress contractility.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions8 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Personal emails, About story and Australian-style copy

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.